Palantir Q2 Hypergrowth Validates Moat, But Valuation Still Prices Perfection

What happened

Palantir's Q2 2026 results delivered 93% revenue growth and a 62% adjusted operating margin, with U.S. commercial revenue up 149% and government up 90%, while U.S. commercial total contract value hit a record $2.132 billion, up 153%. The acceleration undermined bear arguments that AI pilots would fail to convert, as customer growth to 1,049 and RPO expansion suggest broadening demand. Yet the stock at $163 already trades at 129x P/E and 220.7x EV/EBITDA, pricing in sustained >80% revenue growth and clean defense conversion. The DeepValue framework rates PLTR a WAIT with an attractive entry near $130 and trim point above $185, reflecting no margin of safety at current levels. The bear case persists not on execution quality but on valuation and the risk that government funding or commercial conversion normalize faster than the share price assumes.

Implication

Investors should not chase strength above $163. Monitor Q3 for sustained >100% U.S. commercial growth and funded government task-order conversion; if these hold and the stock retrenches toward $130, build a position. Conversely, if growth decelerates below 100% or RPO conversion weakens below 43%, the valuation can compress sharply from current levels. Position sizing should be disciplined given the stock's crowded narrative and founder-dominant governance.

Thesis delta

No change to the overall WAIT rating; the article confirms exceptional execution but does not alter the valuation problem. The update reinforces that bears are losing on fundamentals, yet the stock already discounts upside, so entry discipline becomes more important. The thesis remains that Palantir has a real moat but current price exceeds fair value, with downside to $120 if growth normalizes and upside to $190 only if hypergrowth persists.